Related Experiment Video

Updated: May 24, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Interventional treatment methods in patients with Marfan Syndrome

T Fleck1, M Czerny, E Wolner

  • 1Dept Cardiothoracic Surgery, University of Vienna Medical School, 1090 Vienna, Austria.

Images in Paediatric Cardiology
|February 28, 2012
PubMed

Insights

Marfan syndrome (MS) is a genetic disorder affecting connective tissues. Early detection and lifelong aortic surveillance significantly improve life expectancy for affected individuals.

Area of Science:

  • Genetics and Heritable Diseases
  • Cardiovascular Medicine
  • Connective Tissue Disorders

Background:

  • Marfan syndrome (MS) is an autosomal dominant disorder impacting skeletal, ocular, and cardiovascular systems.
  • Affecting approximately 1 in 10,000 individuals, MS has a significant genetic component, with 25-30% arising from spontaneous mutations.
  • The primary cause of premature mortality in MS patients is aortic dissection and related cardiac complications.

Purpose of the Study:

  • To review the optimal management strategies for Marfan syndrome.
  • To emphasize the critical role of lifelong surveillance, particularly monitoring aortic behavior.
  • To outline current surgical and interventional treatment options for Marfan syndrome.

Main Methods:

  • Review of current medical literature and clinical guidelines.
  • Analysis of advancements in surgical and interventional treatments.
  • Focus on lifelong patient surveillance protocols.

Main Results:

  • Life expectancy for Marfan syndrome patients has improved due to medical and surgical advancements.
  • Preventive aortic replacement strategies have significantly contributed to increased longevity.
  • Ongoing surveillance is crucial for managing cardiovascular manifestations.

Conclusions:

  • Optimal Marfan syndrome management requires lifelong surveillance with a focus on aortic health.
  • Surgical and interventional treatments are key to improving outcomes and life expectancy.
  • Advances in care have substantially enhanced the prognosis for individuals with Marfan syndrome.
Keywords:
Cardiovascular complicationsLong term outcomeMarfan syndromeSurgical techniquesThoracic Surgery

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.